Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

The importance of obesity in diabetes and its treatment with sibutramine

Abstract

Weight gain is a known risk factor for the development of type 2 diabetes and even modest weight reduction can reduce the risk of developing diabetes, so controlling body weight is an important public health goal in the fight against diabetes and its comorbidities. Weight reduction is also a cornerstone of diabetes management, improving glycaemic control and reducing other risk factors associated with this disease. Pharmacotherapies such as sibutramine contribute to the management of type 2 diabetes in overweight and obese patients.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to LF Van Gaal.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Van Gaal, L., Peiffer, F. The importance of obesity in diabetes and its treatment with sibutramine. Int J Obes 25 (Suppl 4), S24–S28 (2001). https://doi.org/10.1038/sj.ijo.0801935

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijo.0801935

Keywords

This article is cited by

  • Sibutramine lost and found

    • O. Bosello
    • M. O. Carruba
    • C. M. Rotella

    Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity (2002)

Search

Quick links